A Trial of SHR-1707 in Healthy Young Adult and Elderly Subjects
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled, single dose escalation phase 1 study to
access the Pharmacokinetics and Pharmacodynamics of Single Intravenous Administration of
SHR-1707